Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- B of A Securities analyst Alec Stranahan downgraded Erasca, Inc. (NASDAQ:ERAS) from Buy to Underperform and slashed the price target from $4 to $1. Erasca shares closed at $1.60 on Tuesday. See how other analysts view this stock.
- Rothschild & Co analyst Harry Read downgraded Accenture plc (NYSE:ACN) from Buy to Neutral and announced a $250 price target. Accenture shares closed at $256.17 on Tuesday. See how other analysts view this stock.
- B of A Securities analyst Jean Ann Salisbury downgraded Phillips 66 (NYSE:PSX) from Buy to Neutral and raised the price target from $144 to $147. Phillips 66 shares closed at $133.84 on Tuesday. See how other analysts view this stock.
- Citigroup analyst Paul Lejuez downgraded Academy Sports and Outdoors, Inc. (NASDAQ:ASO) from Buy to Neutral and lowered the price target from $55 to $50. Academy Sports shares closed at $49.50 on Tuesday. See how other analysts view this stock.
- Rothschild & Co analyst Jamie Clark downgraded Medpace Holdings, Inc. (NASDAQ:MEDP) from Buy to Neutral and raised the price target from $342 to $474. Medpace shares closed at $473.34 on Tuesday. See how other analysts view this stock.
Considering buying ERAS stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock
